Distinct Pathways of VPF/VEGF Receptors

VPF/VEGF 受体的独特途径

基本信息

  • 批准号:
    8704237
  • 负责人:
  • 金额:
    $ 38.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-04-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of our proposal is to elucidate the signaling pathways by which vascular permeability factor/vascular endothelial growth factor (VPF/VEGF, VEGF-A) promotes blood vessel formation and influences microenvironment. VEGF-A participates in a variety of vascular processes including endothelial cell (EC) proliferation, migration, survival, and differentiation (arterial-venous cell fate specification) through its two tyrosine kinase receptors, VEGFR-1 and VEGFR-2 and non-tyrosine kinase receptors neuropilins (NRPs). During the last two cycles of our funding, we defined several diverse and complex pathways of VEGF-A. These pathways focused mainly on proliferation, migration, and survival. Although there is striking evidence for distinct functional roles of VEGF-A-mediated signaling through VEGF receptors (VEGFRs), it is still unclear how certain VEGF-mediated downstream signal transduction cascades selectively potentiate two important functions: promotes EC differentiation and creates EC hyperpermeability. To understand the unique signaling pathways of VEGF-A, we have proposed two aims. Aim 1 will delineate the roles of VEGFR-2 and NRPs for EC differentiation. We will also define the signaling pathways of VEGF-mediated p53 regulation and its role in EC differentiation. Similarly, the key role of Protein Kinase D (PKD) in VEGF-mediated EC differentiation will be evaluated. Whereas, Aim 2 will define the molecular mechanism of VEGF-induced vascular permeability (VP) in real-time. Recently we have developed a heat-inducible VEGF-A transgenic zebrafish model to study VP in real-time. In this aim, we will evaluate the role of individual VEGFRs and the molecules downstream of the pathways that lead to three distinctly different settings: basal vascular permeability (BVP), acute vascular hyperpermeability (AVH), and chronic vascular hyperpermeability (CVH). The proposed studies will elucidate the signaling pathways by which the known as well as unknown molecules mediate the different types of vascular permeability. Hence, the results of the proposed studies will promote understanding of the molecular mechanisms and pathways of these two important functions of VEGF-A and will impact our knowledge of normal physiological processes such as wound healing as well as pathological conditions, including cancer, diabetic retinopathy, and ischemic conditions leading to heart disease and stroke. Lastly, the proposed studies will expand our understanding of VEGF-A signaling as it relates to other VEGF-responsive cell types including circulating progenitor cells, bone cells, and neuronal progenitors.
描述(由申请人提供):我们提案的长期目标是阐明血管渗透性因子/血管内皮生长因子(VPF/VEGF,VEGF-A)促进血管形成和影响微环境的信号通路。VEGF-A通过其两种酪氨酸激酶受体VEGFR-1和VEGFR-2以及非酪氨酸激酶受体神经纤毛蛋白(NRP)参与多种血管过程,包括内皮细胞(EC)增殖、迁移、存活和分化(动脉-静脉细胞命运特化)。在过去的两个资助周期中,我们确定了VEGF-A的几个不同而复杂的途径。这些途径主要集中在增殖、迁移和生存上。虽然有明显的证据表明,VEGF-A介导的信号转导通过VEGF受体(VEGF)的不同功能的作用,它仍然不清楚某些VEGF介导的下游信号转导级联如何选择性地加强两个重要的功能:促进EC分化和创建EC高通透性。为了了解VEGF-A独特的信号通路,我们提出了两个目标。目的1阐明VEGFR-2和NRP在EC分化中的作用。我们还将确定VEGF介导的p53调控的信号通路及其在EC分化中的作用。类似地,将评估蛋白激酶D(PKD)在VEGF介导的EC分化中的关键作用。而目标2将实时定义VEGF诱导的血管通透性(VP)的分子机制。最近,我们建立了一个热诱导VEGF-A转基因斑马鱼模型来实时研究VP。在这一目标中,我们将评估单个VEGF受体和导致三种明显不同的设置的途径下游的分子的作用:基础血管通透性(BVP),急性血管通透性过高(AVH)和慢性血管通透性过高(CVH)。拟议的研究将阐明已知和未知分子介导不同类型的血管通透性的信号通路。因此,拟议研究的结果将促进对VEGF-A这两种重要功能的分子机制和途径的理解,并将影响我们对正常生理过程的认识,如伤口愈合以及病理条件,包括癌症,糖尿病视网膜病变和导致心脏病和中风的缺血性疾病。最后,拟议的研究将扩大我们对VEGF-A信号传导的理解,因为它与其他VEGF应答细胞类型有关,包括循环祖细胞,骨细胞和神经元祖细胞。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.
  • DOI:
    10.2147/ijn.s24074
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Srinivas P;Patra CR;Bhattacharya S;Mukhopadhyay D
  • 通讯作者:
    Mukhopadhyay D
Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes.
Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.
  • DOI:
    10.1182/blood-2009-10-248856
  • 发表时间:
    2010-06
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    A. Verma;Resham Bhattacharya;Indulekha Remadevi;Keguo Li;K. Pramanik;G. V. Samant;Mark A Horswill;C. Chun;Baofeng Zhao;E. Wang;R. Miao;D. Mukhopadhyay;R. Ramchandran;G. Wilkinson
  • 通讯作者:
    A. Verma;Resham Bhattacharya;Indulekha Remadevi;Keguo Li;K. Pramanik;G. V. Samant;Mark A Horswill;C. Chun;Baofeng Zhao;E. Wang;R. Miao;D. Mukhopadhyay;R. Ramchandran;G. Wilkinson
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.
  • DOI:
    10.1158/0008-5472.can-09-2552
  • 发表时间:
    2009-12-01
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Bhattacharya R;Nicoloso M;Arvizo R;Wang E;Cortez A;Rossi S;Calin GA;Mukherjee P
  • 通讯作者:
    Mukherjee P
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.
  • DOI:
    10.4049/jimmunol.1101644
  • 发表时间:
    2012-02-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zhao X;Bose A;Komita H;Taylor JL;Chi N;Lowe DB;Okada H;Cao Y;Mukhopadhyay D;Cohen PA;Storkus WJ
  • 通讯作者:
    Storkus WJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBABRATA MUKHOPADHYAY其他文献

DEBABRATA MUKHOPADHYAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBABRATA MUKHOPADHYAY', 18)}}的其他基金

Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma
肿瘤靶向药物递送纳米平台克服胶质母细胞瘤治疗耐药性
  • 批准号:
    10558857
  • 财政年份:
    2022
  • 资助金额:
    $ 38.64万
  • 项目类别:
Career Developmental Program
职业发展计划
  • 批准号:
    8738920
  • 财政年份:
    2014
  • 资助金额:
    $ 38.64万
  • 项目类别:
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
使用肽化学靶向胰腺癌:从实验室到临床
  • 批准号:
    8433232
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
使用肽化学靶向胰腺癌:从实验室到临床
  • 批准号:
    8056510
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Tumor Microenvironment/Angiogenesis Training Grant
肿瘤微环境/血管生成培训补助金
  • 批准号:
    8259210
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
使用肽化学靶向胰腺癌:从实验室到临床
  • 批准号:
    8607838
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Tumor Microenvironment/Angiogenesis Training Grant
肿瘤微环境/血管生成培训补助金
  • 批准号:
    8472454
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Tumor Microenvironment/Angiogenesis Training Grant
肿瘤微环境/血管生成培训补助金
  • 批准号:
    8069951
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
使用肽化学靶向胰腺癌:从实验室到临床
  • 批准号:
    8212469
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:
Tumor Microenvironment/Angiogenesis Training Grant
肿瘤微环境/血管生成培训补助金
  • 批准号:
    7853825
  • 财政年份:
    2010
  • 资助金额:
    $ 38.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了